Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person25
Mereo BioPharma Group plc
Company
MEARS GROUP PLC
Company · 03232863
MONY GROUP PLC
Company · 06160943
YU GROUP PLC
Company · 10004236
GT Biopharma, Inc.
Company
EDX MEDICAL GROUP PLC
Company · 13277385
NCC GROUP PLC
Company · 04627044
BREEDON GROUP PLC
Company · 14739556
MOONPIG GROUP PLC
Company · 13096622
OSB GROUP PLC
Company · 11976839
SSP GROUP PLC
Company · 05735966
HARWORTH GROUP PLC
Company · 02649340
NIOX GROUP PLC
Company · 05822706
KIER GROUP PLC
Company · 02708030
SERCO GROUP PLC
Company · 02048608
Genuit Group plc
Company · 06059130
OCADO GROUP PLC
Company · 07098618
PENNON GROUP PLC
Company · 02366640
EVERYMAN MEDIA GROUP PLC
Company · 08684079
Propanc Biopharma, Inc.
Company
Klarna Group plc
Company
VISTRY GROUP PLC
Company · 00306718
Tribal Group Plc
Company · 04128850
SMITHS GROUP PLC
Company · 00137013
TEKMAR GROUP PLC
Company · 11383143
Primary record5
BANK OF AMERICA CORP /DE/ filed SCHEDULE 13G/A
0000070858-26-000531.txt : 20261028 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0000070858 XXXXXXXX LIVE 1 Ordinary Shares 09/30/2026 0001719714 Mereo BioPharma Group plc G6014T100 ONE CAVENDISH PLACE FOURTH FL
Mereo BioPharma Group plc filed 8-K
Item 3.01 - Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing As previously disclosed, on February 17, 2026, Mereo BioPharma Group plc (the Company ) received a written n
Mereo BioPharma Group plc filed SCHEDULE 13G/A
0000935836-26-000413.txt : 20260814 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0000935836-26-000265 0001587114 XXXXXXXX LIVE 2 Ordinary Shares 06/30/2026 0001719714 Mereo BioPharma Group plc 589492107 ONE CAVE
Mereo BioPharma Group plc filed 8-K
Item 2.02 Results of Operations and Financial Condition. On August 11, 2026, Mereo BioPharma Group plc announced its financial results for the second quarter ended June 30, 2026 and provided an update on recent corporate
Mereo BioPharma Group plc filed 8-K
Item 1.01 Entry into a Material Definitive Agreement On August 11, 2026, Mereo BioPharma Group plc (the “Company” or "Mereo") entered into an Option and License Agreement (the “Agreement”) with Sentynl Therapeutics, Inc.